Search Results
Results found for "Pfizer"
- How Schild Analysis Protects Your Conclusions in GPCR Research
Breakthroughs this week: McGPCR multimodal model; Endocrine Metabolic GPCRs 2026; Pfizer–Metsera acquisition This Week in Premium: Sneak Peek Industry insights: Domain CMO; Pfizer–Metsera; Novo Nordisk strategy
- Oxford Professor Of Chemistry And Founder Of Therapeutic Company Wins Two International Awards
by the fact that other winners this year are the co-founders of BioNTech for their invention of the (Pfizer
- Applications of Cryo-EM in small molecule and biologics drug design
examples of impacts from cryo-EM in therapeutics design, focusing largely on its implementation at Pfizer
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
Aaron McGrath from Takeda 🎥 Interview with Kris Borzilleri & Alison Heick Varghese from Pfizer 🎥
- 📰 GPCR Weekly News
Sosei Heptares' Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
Solubilization, Orphans & Lipid Systems In a conversation with Alison Heick Varghese and Kris Borzilleri (Pfizer
- 📰 GPCR Weekly News, September 18 to 24, 2023
BenevolentAI, Exscientia on the comeback trail after securing separate AI drug discovery deals with Merck KGaA Pfizer
- 📰 GPCR Weekly News, December 11 to 17, 2023
Out-Licensing Agreement with Bridge Biotherapeutics in Idiopathic Pulmonary Fibrosis Former execs from Pfizer
- 📰 GPCR Weekly News, October 30 to November 4, 2023
Award for GPCR Research Bryan Roth, Natural Products, and the John Daly Legacy Sosei Heptares’ Partner, Pfizer
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Could Help Drug Developers Find Buried Treasures Edelris Announces Research Services Agreement with Pfizer
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
appreciated when talking about SCRAs (Synthetic Cannabinoid Agonists), as one of the series developed by Pfizer
